SCHEMBL10123086

SCHEMBL10123086

CC(=O)Oc1cc2c(cc1F)C1(OC(=O)c3cc(C(=O)Cl)ccc31)c1cc(F)c(C)cc1O2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSTP1 P09211 1/20 0.47
MAPT P10636 4/20 0.47
MEN1 O00255 3/20 0.47
HTT P42858 3/20 0.47
KMT2A Q03164 3/20 0.47
LMNA P02545 3/20 0.47
USP2 O75604 2/20 0.47
ALDH1A1 P00352 2/20 0.47
FTO Q9C0B1 10/20 0.39
HPGD P15428 2/20 0.36
CYP2C19 P33261 1/20 0.36
RECQL P46063 1/20 0.36
BLM P54132 1/20 0.36
SMAD3 P84022 1/20 0.36
PRMT1 Q99873 1/20 0.36
ACE2 Q9BYF1 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
CYP3A4 P08684 1/20 0.35
POLB P06746 1/20 0.34
ALOX12 P18054 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10147637 0.95 MAPT (0.51) GSTP1MAPTMEN1HTTKMT2A
SCHEMBL10123085 0.92 ALDH1A1 (0.48) GSTP1MAPTMEN1HTTKMT2A
SCHEMBL13212097 0.86 ALDH1A1 (0.52) GSTP1MAPTMEN1HTTKMT2A
SCHEMBL30378493 0.86 ALDH1A1 (0.52) GSTP1MAPTMEN1HTTKMT2A
SCHEMBL30378455 0.81 MAPT (0.66) GSTP1MAPTMEN1HTTKMT2A
SCHEMBL12387963 0.80 MAPT (0.51) GSTP1MAPTMEN1HTTKMT2A
SCHEMBL22434381 0.79 GSTP1 (0.45) GSTP1MAPTMEN1HTTKMT2A
SCHEMBL22434392 0.79 GSTP1 (0.44) GSTP1MAPTMEN1HTTKMT2A
SCHEMBL19878378 0.79 ALDH1A1 (0.49) GSTP1MAPTMEN1HTTKMT2A
SCHEMBL30378575 0.79 ALDH1A1 (0.49) GSTP1MAPTMEN1HTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9846168-B2 Fluorescent metal ion indicators with large stokes shifts Life Technologies Corporation (US) 2017-12-19 US disclosed
US-20160305964-A1 Fluorescent Metal Ion Indicators with Large Stokes Shifts MOLECULAR PROBES, INC. 2016-10-20 US disclosed
US-9372181-B2 Fluorescent metal ion indicators with large stokes shifts Life Technologies Corporation (US) 2016-06-21 US disclosed
US-20140363824-A1 Fluorescent Metal Ion Indicators with Large Stokes Shifts MOLECULAR PROBES, INC. 2014-12-11 US disclosed
US-8785208-B2 Fluorescent metal ion indicators with large stokes shifts Life Technologies Corporation (US) 2014-07-22 US disclosed
US-20120009683-A1 Fluorescent Metal Ion Indicators with Large Stokes Shifts Life Technologies Corporation (US) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120009683-A1 Fluorescent Metal Ion Indicators with Large Stokes Shifts SARAF, STIM1, ORAI1 GSTP1 2822/4885MAPT 1199/4885MEN1 137/4885
US-20160305964-A1 Fluorescent Metal Ion Indicators with Large Stokes Shifts SARAF, STIM1, ORAI1 GSTP1 2822/4885MAPT 1199/4885MEN1 137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.